fda food and drug administration - Search News

FDA, Ozempic and shortage

The Hill on MSN · 4h

Ozempic and Wegovy officially moved off FDA’s drug shortage list

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration’s (FDA) drug shortage list

The Washington Post on MSN · 5h

FDA says Ozempic shortage is over, chilling boom in off-brand versions

The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the end to the booming market for cheaper versions made by pharmacies.

Hosted on MSN · 5h

Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the popular diabetes and obesity treatments continue to improve, federal regulators said Friday.

Mirum, FDA and Pharmaceuticals

Reuters on MSN · 5h

US FDA approves Mirum Pharma's genetic disorder drug

The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first treatment for a rare condition that interferes with the body's ability to process cholesterol.

MarketWatch · 8h

FDA Approves Mirum Pharmaceuticals Treatment for Lipid-Storage Disease

The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli to treat Cerebrotendinous Xanthoma, a very rare lipid-storage disease. The approval makes Ctexli, or chenopod, the first FDA-approved drug to treat CTX,

Business Insider · 8h

FDA approves Mirum treatment for cerebrotendinous xanthomatosis

The Food and Drug Administration approved Ctexli for the treatment of cerebrotendinous xanthomatosis in adults. “Ctexli is the first

Fierce Healthcare5h

FDA declares semaglutide shortage over, spelling end to compounded GLP-1 market

The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...

3d

FDA Food Division Leader Quits After Staff Layoffs

Jim Jones, a deputy commissioner at the U.S. Food and Drug Administration, resigned Monday following what he called the ...

5hon MSN

Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on notice

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and ...

4don MSN

Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products

The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this ...

Dozens of attorneys general urge FDA to crack down on counterfeit obesity drugs

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

3don MSN

FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea

Key Takeaways Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review ...

2hon MSN

Nut recall set at highest FDA level

A batch of recalled Wegmans nuts has been issued a Class II risk classification by the U.S. Food and Drug Administration ( ...

Make Food “Healthy” Again: FDA’s Resolution for a Healthier 2025

The U.S. Food and Drug Administration (FDA) began 2025 with a resolution to make food “healthy” again by announcing a trio of new final and ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results